CardioWear: A Wearable System for Ambulatory Cardiac Monitoring (aECG)

Information

  • Research Project
  • 8315302
  • ApplicationId
    8315302
  • Core Project Number
    R43HL114240
  • Full Project Number
    1R43HL114240-01
  • Serial Number
    114240
  • FOA Number
    PA-11-096
  • Sub Project Id
  • Project Start Date
    6/8/2012 - 12 years ago
  • Project End Date
    6/7/2013 - 11 years ago
  • Program Officer Name
    LEE, ALBERT
  • Budget Start Date
    6/8/2012 - 12 years ago
  • Budget End Date
    6/7/2013 - 11 years ago
  • Fiscal Year
    2012
  • Support Year
    01
  • Suffix
  • Award Notice Date
    6/7/2012 - 12 years ago
Organizations

CardioWear: A Wearable System for Ambulatory Cardiac Monitoring (aECG)

DESCRIPTION (provided by applicant): Orbital Research proposes the development of a fully wearable sensor, ambulatory ECG monitoring device called CardioWear to enable continuous cardio- electrophysiology monitoring in home/ambulatory based conditions. CardioWear will be a wearable-garment device, equipped with Orbital Research dry ECG electrodes to monitor cardiac markers such as heart rate and rhythm, heart rate variability and cardiac events for long duration. CardioWear will be comfortable to wear, easy to don and doff, convenient to use and maintain. The platform harness has in part been developed for acute ECG monitoring for NASA applications. ORI will use a custom designed ultra-low power, machine to machine electronic data transceiver module to up-link aECG data to a cellular network (i.e Sprint's Telehealth Solutions) for continuous analysis, storage and display of the recorded metrics. The cloud communication system will allow real-time inspection and analysis of aECG data collected and sent through the cellular portal. The intended use of the system is for moderate-to-high risk patients that can benefit from continuous monitoring for both disease management and preventive medicine reasons. Overall, the intent is to develop a wearable platform that outperforms conventional ambulatory event or Holter monitors which depend on adhesive tape/gel-based electrodes. The industry driver for CardioWear includes current health care initiatives which are focused on improving response time and providing better care for cardiac patients. By improving monitoring capabilities, CardioWear will reduce health care costs, improve outcomes and save lives. PUBLIC HEALTH RELEVANCE: Cardio Wear system provides a feasible solution for the established clinical and technical needs currently associated, vastly limiting aECG studies. The resultant Cardio Wear platform will improve patient compliance, reduce disease and treatment related costs, advance monitoring and diagnostic capabilities, all these together will improve the outcomes for the patients. Keywords: aECG, Holter, electrode, telemetry, ambulatory

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    162170
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:162170\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ORBITAL RESEARCH, INC.
  • Organization Department
  • Organization DUNS
    557510336
  • Organization City
    CLEVELAND
  • Organization State
    OH
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    441033757
  • Organization District
    UNITED STATES